TROUGH CONCENTRATIONS OF CYCLOSPORINE IN BLOOD FOLLOWING ADMINISTRATION WITH GRAPEFRUIT JUICE

被引:91
作者
DUCHARME, MP
PROVENZANO, R
DEHOORNESMITH, M
EDWARDS, DJ
机构
[1] WAYNE STATE UNIV, COLL PHARM & ALLIED HLTH PROFESS, DEPT PHARM PRACTICE, DETROIT, MI 48202 USA
[2] ST JOHN HOSP & MED CTR, DEPT TRANSPLANT SURG, DETROIT, MI USA
[3] DETROIT RECEIVING HOSP & UNIV HLTH CTR, DEPT PHARM SERV, DETROIT, MI 48202 USA
[4] ST JOHN HOSP & MED CTR, DEPT PHARM, DETROIT, MI USA
关键词
CYCLOSPORINE; GRAPEFRUIT JUICE; CYP3A4; CYTOCHROME P-450;
D O I
10.1111/j.1365-2125.1993.tb00395.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Components of grapefruit juice have been shown to inhibit CYP3A4 activity, the enzyme involved in cyclosporine metabolism. Eleven medically stable patients (seven males, four females) receiving cyclosporine following kidney transplantation were instructed to take their usual dose of cyclosporine with water for 1 week (Phase 1), with grapefruit juice (8 ounces) for 1 week (Phase 2) and again with water for 1 week (Phase 3). Trough blood samples were obtained at the end of each phase for measurement of cyclosporine concentration using a specific monoclonal whole blood radioimmunoassay. Cyclosporine trough concentrations averaged 116.9 +/- 51.6 ng ml-1 in the first phase, 145.3 +/- 44.7 ng ml-1 with grapefruit j uice (P < 0. 05 compared with the first and third phases) and 111. 2 +/- 56.1 ng ml-1 in the third phase. Cyclosporine concentrations increased in 8 of 11 patients when given with grapefruit juice (mean increase 32%; range -4 to 97%) and declined in 10 of 11 when subjects resumed taking cyclosporine with water (mean decrease 27%). These results suggest that grapefruit juice increases trough concentrations of cyclosporine in blood, possibly by inhibiting pre-hepatic gut wall metabolism, and could be useful in optimizing therapy with this drug.
引用
收藏
页码:457 / 459
页数:3
相关论文
共 12 条
  • [1] PHARMACOKINETIC INTERACTION BETWEEN CYCLOSPORINE AND DILTIAZEM
    BROCKMOLLER, J
    NEUMAYER, HH
    WAGNER, K
    WEBER, W
    HEINEMEYER, G
    KEWITZ, H
    ROOTS, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (03) : 237 - 242
  • [2] EDGAR B, 1992, EUR J CLIN PHARMACOL, V42, P313
  • [3] GUENGERICH FP, 1990, CARCINOGENESIS, V11, P2275, DOI 10.1093/carcin/11.12.2275
  • [4] CYCLOSPORIN-ERYTHROMYCIN INTERACTION IN RENAL-TRANSPLANT PATIENTS
    GUPTA, SK
    BAKRAN, A
    JOHNSON, RWG
    ROWLAND, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (04) : 475 - 481
  • [5] EVIDENCE FOR PREHEPATIC METABOLISM OF ORAL CYCLOSPORINE IN CHILDREN
    HOPPU, K
    KOSKIMIES, O
    HOLMBERG, C
    HIRVISALO, EL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (04) : 477 - 481
  • [6] 1ST-PASS METABOLISM OF CYCLOSPORINE BY THE GUT
    KOLARS, JC
    AWNI, WM
    MERION, RM
    WATKINS, PB
    [J]. LANCET, 1991, 338 (8781) : 1488 - 1490
  • [7] CYCLOSPORINE METABOLISM IN HUMAN-LIVER - IDENTIFICATION OF A CYTOCHROME-P-450III GENE FAMILY AS THE MAJOR CYCLOSPORINE-METABOLIZING ENZYME EXPLAINS INTERACTIONS OF CYCLOSPORINE WITH OTHER DRUGS
    KRONBACH, T
    FISCHER, V
    MEYER, UA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (06) : 630 - 635
  • [8] MINISCALCO A, 1992, J PHARMACOL EXP THER, V261, P1195
  • [9] CLINICAL PHARMACOKINETICS OF CYCLOSPORINE
    PTACHCINSKI, RJ
    VENKATARAMANAN, R
    BURCKART, GJ
    [J]. CLINICAL PHARMACOKINETICS, 1986, 11 (02) : 107 - 132
  • [10] GRAPEFRUIT JUICE AND CIMETIDINE INHIBIT STEREOSELECTIVE METABOLISM OF NITRENDIPINE IN HUMANS
    SOONS, PA
    VOGELS, BAPM
    ROOSEMALEN, MCM
    SCHOEMAKER, HC
    UCHIDA, E
    EDGAR, B
    LUNDAHL, J
    COHEN, AF
    BREIMER, DD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (04) : 394 - 403